EUVIMEDEUVIMED entdecken
Open Access

Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome

Ana Y Caceres Lessa, Adam Edwinson, Hiroki Sato, Lu Yang, Antonio Berumen, Margaret Breen-Lyles, Anjali Byale, Michael Ryks, Ashley Keehn, Michael Camilleri, Gianrico Farrugia, Jun Chen und 4 weitere

Clinical Gastroenterology and Hepatology · 2025

DOI: 10.1016/j.cgh.2024.06.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Ana Y Caceres Lessa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Colon, Transcriptome, Metabolome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Postinfection irritable bowel syndrome (PI-IBS) is well-known epidemiologically; however, its physiological and molecular characteristics are not well studied. We aimed to determine the physiological phenotypes, colonic transcriptome, fecal microbiome, and metabolome in PI-IBS. METHODS: Fifty-one Rome III Campylobacter PI-IBS patients and 39 healthy volunteers (HV) were enrolled. Participants completed questionnaires, in vivo intestinal permeability, gastrointestinal transit, and rectal sensation. Fecal samples were collected for shotgun metagenomics, untargeted metabolomics, and sigmoid colonic biopsies for bulk RNAseq. Differential gene expression, differences in microbiota composition, and metabolite abundance were determined. Gene and metabolite clusters were identified via weighted gene correlation network analysis and correlations with clinical and physiological parameters determined. RESULTS: PI-IBS (59% female; 46 ± 2 years) and HV (64% female; 42 ± 2 years) demographics were comparable. Mean IBS-symptom severity score was 227; 94% were nonconstipation. Two- to 24-hour lactulose excretion was increased in PI-IBS, suggesting increased colonic permeability (4.4 ± 0.5 mg vs 2.6 ± 0.3 mg; P = .01). Colonic transit and sensory thresholds were similar between the 2 groups. Overall, expression of 2036 mucosal genes and 223 fecal metabolites were different, with changes more prominent in females. Fecal N-acetylputrescine was increased in PI-IBS and associated with colonic permeability, worse diarrhea, and negatively correlated with abundance of Collinsella aerofaciens. Histamine and N-acetylhistamine positively associated with 2- to 24-hour lactulose excretion. Eight weighted gene coexpression modules significantly correlated with phenotypes (sex, stool frequency, colonic permeability, transit). CONCLUSIONS: Campylobacter PI-IBS patients demonstrate higher colonic permeability, which associated with changes in polyamine and histamine metabolites. Female patients demonstrated greater molecular changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeColonTranscriptomeMetabolomeHumansFemaleMaleAdultMiddle AgedFecesPermeabilityMetabolomicsGastrointestinal Microbiome

Stichwörter der Autor:innen

Barrier FunctionDisorders of Gut-Brain InteractionsGastroenteritisHistamineMicrobiotaPolyamines

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota.
  • Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University…
  • Division of Computational Biology, Mayo Clinic, Rochester, Minnesota.
  • Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Medicine, Boston University, Boston, Massachusetts.
  • Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Medicine, University of Pittsburgh Medical Center, McKeesport, Pennsylvania.
  • Minnesota Department of Health, St. Paul, Minnesota.

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • NIDDK

Zitieren

APA

Caceres Lessa, A. Y., Edwinson, A., Sato, H., Yang, L., Berumen, A., Breen-Lyles, M., Byale, A., Ryks, M., Keehn, A., Camilleri, M., Farrugia, G., Chen, J., Decuir, M., Smith, K., Dasari, S., & Grover, M. (2025). Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.06.028

Vancouver

Caceres Lessa AY, Edwinson A, Sato H, Yang L, Berumen A, Breen-Lyles M, et al. Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2024.06.028

BibTeX
@article{CaceresLessa2025,
  author = {Caceres Lessa, Ana Y and Edwinson, Adam and Sato, Hiroki and Yang, Lu and Berumen, Antonio and Breen-Lyles, Margaret and Byale, Anjali and Ryks, Michael and Keehn, Ashley and Camilleri, Michael and Farrugia, Gianrico and Chen, Jun and Decuir, Marijke and Smith, Kirk and Dasari, Surendra and Grover, Madhusudan},
  title = {Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1016/j.cgh.2024.06.028}
}
Kostenlos starten →